A Phase 1 Multiple Dose Study of Tirzepatide in Chinese Patients with Type 2 Diabetes.
Ping FengXiaoyan ShengYongjia JiShweta UrvaFeng WangSheila MillerChenxi QianZhenmei AnYi Min CuiPublished in: Advances in therapy (2023)
ClinicalTrials.gov: NCT04235959.
Keyphrases